Corient Capital Partners’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$365K Buy
2,034
+69
+4% +$13.7K 0.03% 413
2022
Q2
$352K Buy
1,965
+52
+3% +$13.3K 0.03% 431
2022
Q1
$650K Buy
1,913
+179
+10% +$60.5K 0.04% 334
2021
Q4
$642K Sell
1,734
-125
-7% -$47.4K 0.04% 325
2021
Q3
$733K Buy
1,859
+31
+2% +$14.3K 0.05% 274
2021
Q2
$842K Buy
1,828
+75
+4% +$30.2K 0.06% 239
2021
Q1
$655K Buy
1,753
+255
+17% +$104K 0.06% 263
2020
Q4
$539K Buy
1,498
+45
+3% +$14.3K 0.05% 262
2020
Q3
$437K Buy
1,453
+32
+2% +$11K 0.05% 279
2020
Q2
$512K Buy
+1,421
New +$457K 0.06% 245
2020
Q1
Sell
-1,275
Closed -$412K 452
2019
Q4
$412K Buy
1,275
+225
+21% +$68.2K 0.05% 307
2019
Q3
$311K Sell
1,050
-604
-37% -$178K 0.04% 341
2019
Q2
$592K Buy
1,654
+529
+47% +$167K 0.09% 211
2019
Q1
$340K Buy
1,125
+25
+2% +$7.29K 0.06% 268
2018
Q4
$321K Buy
+1,100
New +$341K 0.06% 255

Other funds holding ILMN

Corient Capital Partners's ILMN Position: Q3 2022 in Review

Corient Capital Partners increased its Illumina (ILMN) stake by 3.5% in Q3 2022, buying an estimated $13.7K and bringing the position to 2,034 shares worth $365K. The position accounts for 0.03% of the portfolio, ranked #413.

Corient Capital Partners first reported a position in ILMN in Q4 2018 and has held it in 15 quarters since. The position peaked at $842K in Q2 2021. 897 funds tracked by Wall St. Rank hold ILMN as of Q3 2022.

  • Corient Capital Partners held 2,034 shares of Illumina worth $365K as of Q3 2022.
  • Corient Capital Partners bought 69 Illumina shares in Q3 2022, an estimated $13.7K.
  • Illumina made up 0.03% of Corient Capital Partners's portfolio in Q3 2022, its #413 holding.
  • Corient Capital Partners first reported a position in Illumina in Q4 2018 and has held it in 15 quarters since.
  • Corient Capital Partners's Illumina position peaked at $842K in Q2 2021.
  • 897 funds tracked by Wall St. Rank held Illumina as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.